METHODS, REGIMENS, COMBINATIONS & ANTAGONISTS
The invention relates to treating or preventing anemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects. 本发明涉及治疗或预防如...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
04.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The invention relates to treating or preventing anemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects.
本发明涉及治疗或预防如哺乳动物或人等受试者的贫血。具体地,本发明解决了中度到重度贫血。另外,本发明提供了用于免除对受试者施用红细胞生成刺激剂(ESA)的手段。 |
---|---|
Bibliography: | Application Number: CN201780027052 |